[1]张霞,范涛,袁惠,等.隔姜脐灸联合痛泻要方加减治疗腹泻型肠易激综合征疗效观察[J].西部中医药,2023,36(03):131-134.[doi:10.12174/j.issn.2096-9600.2023.03.26]
　ZHANG Xia,FAN Tao,YUAN Hui,et al.Clinical Observation on Umbilical Moxibustion on Ginger Combined with Modified Tongxie Yaofang in the Treatment of Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2023,36(03):131-134.[doi:10.12174/j.issn.2096-9600.2023.03.26]
点击复制

隔姜脐灸联合痛泻要方加减治疗腹泻型肠易激综合征疗效观察
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年03期
页码:
131-134
栏目:
出版日期:
2023-03-14

文章信息/Info

Title:
Clinical Observation on Umbilical Moxibustion on Ginger Combined with Modified Tongxie Yaofang in the Treatment of Irritable Bowel Syndrome
作者:
张霞, 范涛, 袁惠, 许俊英
成都市温江区人民医院，四川 成都 611130
Author(s):
ZHANG Xia, FAN Tao, YUAN Hui, XU Junying
Wenjiang District People's Hospital of Chengdu, Chengdu 611130, China
关键词:
肠易激综合征; 腹泻型; 隔姜脐灸; 痛泻要方; 疗效观察
Keywords:
irritable bowel syndrome;  diarrhea type; umbilical moxibustion on ginger; clinical observation
分类号:
R574
DOI:
10.12174/j.issn.2096-9600.2023.03.26
文献标志码:
B
摘要:
目的观察隔姜脐灸联合痛泻要方加减治疗腹泻型肠易激综合征（irritable bowel syndrome，IBS）的临床疗效。 方法将腹泻型IBS患者96例采用随机数字表法分为观察组、对照组各48例。对照组行西医常规治疗，观察组在此基础上加隔姜脐灸联合痛泻要方加减治疗。比较两组患者临床疗效、证候评分、炎症因子水平、神经递质及不良反应。 结果总有效率观察组为93.75%，高于对照组的79.17%（P＜0.05）。治疗后两组患者主症与次症评分均下降，观察组下降更明显（P＜0.05）。治疗后两组患者肿瘤坏死因子α、干扰素γ及人血清P物质（SP）、5羟色胺、人血浆神经肽Y水平均下降，观察组下降更明显；治疗后两组患者白细胞介素10水平均升高，观察组升高更明显（P＜0.05）。对照组不良反应为3例（6.25%），与观察组的4例（8.33%）比较差异无统计学意义（P＞0.05）。 结论西医常规治疗基础上加隔姜脐灸联合痛泻要方加减在提高腹泻型IBS患者临床疗效，降低证候评分，缓解炎症反应并降低脑肠肽水平方面优于单独西医常规治疗，且具有较高的安全性。
Abstract:
ObjectiveTo observe clinical effects of umbilical moxibustion on ginger combined with modified Tongxie Yaofang in the treatment of irritable bowel syndrome (IBS). MethodsAll 96 IBS patients were allocated to the observation group and the control group by using random number table method, 48 cases in each group. The control group performed conventional Western medicine therapy, and the observation group was treated by umbilical moxibustion on ginger and modified Tongxie Yaofang on the foundation of conventional Western medicine therapy. To compare clinical effects, syndrome scales, the levels of inflammatory factor, neurotransmitter and adverse reactions between both groups. ResultsTotal effective rate of the observation group was 93.75%, higher than 79.17% of the control group (P<0.05). The scores of the main symptom and the secondary symptom reduced in both groups after the treatment, the decrease of the observation group was more noticeable (P<0.05). After the treatment, the levels of TNF-α, IFN-γ, SP, 5-HT and NPY decreased in both groups, the decrease of the observation group was more remarkable; after the treatment, the levels of IL-10 increased in both groups, and the increase of the observation group was more significant (P<0.05). The difference had no statistical meaning when three cases suffering adverse reaction (6.25%) in the control group were compared with four cases (8.33%) of the observation group (P>0.05). ConclusionOn the foundation of routine therapy, umbilical moxibustion on ginger and modified Tongxie Yaofang is superior to single routine therapy in raising clinical effects of IBS patients, decreasing syndrome scales, relieving the inflammatory response and reducing the levels of braingut petide, and the treatment has higher safety.

相似文献/References:

[1]信 楠,杨培培 指导：沈舒文.健脾导滞汤治疗肠易激综合征30例[J].西部中医药,2012,25(10):91.
　XIN Nan,YANG Pei-pei Director: SHEN Shu-wen.JianPi DaoZhiTang in Treating 30 Cases of Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2012,25(03):91.
[2]张晓宁,马玉侠.隔药灸脐与匹维溴铵对脾虚型肠易激综合征患者尿液代谢组学影响的异同[J].西部中医药,2015,28(07):1.
[3]杨磊,孙洁,李滢,等.电针对IBS模型大鼠肠系膜微血管管径与血浆CGRP、VIP水平的影响*[J].西部中医药,2014,27(03):22.
　YANG Lei,SUN Jie,LI Ying,et al.Influence of Acusector on the Levels of CGRP and VIP in the Plasma and Mesenteric Microvascular Caliber of IBS Rat Model[J].Western Journal of Traditional Chinese Medicine,2014,27(03):22.
[4]梁胜斌,杨世洁,李共信,等.敦煌葆元汤治疗肝郁脾虚型肠易激综合征的临床观察[J].西部中医药,2013,26(07):79.
　LIANG Shengbin,YANG Shijie,LI Gongxin,et al.Clinical Observation on DunHuang BaoYuanTang in Treating Irrirable Bowel Syndrome of Liver Qi Stagnation and Spleen Deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(03):79.
[5]贾晓东,鱼涛△.温中散外敷热疗法配合参苓白术散内服治疗脾胃虚弱腹泻型肠易激综合征疗效观察[J].西部中医药,2018,31(11):81.
　JIA Xiaodong,YU Tao.Clinical Observation on Heat Therapy of WenZhong Powder for External Application and Oral Administration of ShenLing BaiZhu Powder in the Treatment for IBS-D of Spleen-stomach Weakness Pattern[J].Western Journal of Traditional Chinese Medicine,2018,31(03):81.
[6]赵建民.姜黄-茴香胶囊治疗肠易激综合征70例[J].西部中医药,2018,31(12):63.
　ZHAO Jianmin.JiangHuang-HuiXiang Capsules in Treating 70 Cases of Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2018,31(03):63.
[7]张媛媛,舒劲,雷珉.舒劲教授从肝脾论治便秘型肠易激综合征[J].西部中医药,2021,34(02):59.[doi:10.12174/j.issn.2096-9600.2021.02.15]
　ZHANG Yuanyuan,SHU Jin,LEI Min.Professor Shu Jin′s Experience in Treating Constipation Predominant Irritable Bowel Syndrome from Liver and Spleen[J].Western Journal of Traditional Chinese Medicine,2021,34(03):59.[doi:10.12174/j.issn.2096-9600.2021.02.15]
[8]王喜红,谢春娥,薛晓轩,等.肠易激综合征的中西医治疗进展[J].西部中医药,2020,33(03):156.[doi:10.12174/j.issn.1004-6852.2020.03.44]
　WANG Xihong,XIE Chune,XUE Xiaoxuan,et al.The Progress in the Treatment of Irritable Bowel Syndrome by Integrative Medicine[J].Western Journal of Traditional Chinese Medicine,2020,33(03):156.[doi:10.12174/j.issn.1004-6852.2020.03.44]
[9]冯文林,伍海涛.经方治疗肠易激综合征研究概况[J].西部中医药,2021,34(01):134.[doi:10.12174/j.issn.2096-9600.2021.01.35]
　FENG Wenlin,WU Haitao.Research Overview of Classic Prescription in Treating Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2021,34(03):134.[doi:10.12174/j.issn.2096-9600.2021.01.35]
[10]耿琦,丛军.肠吉泰对肠易激综合征内脏高敏感大鼠PAR2、PKCε、TRPV1蛋白表达的影响[J].西部中医药,2022,35(04):60.[doi:10.12174/j.issn.2096-9600.2022.04.13]
　GENG Qi,CONG Jun.Effects of Changjitai Decoction on the Expressions of PAR2, PKCε and TRPV1 Protein in Visceral Hypersensitivity Rats with Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2022,35(03):60.[doi:10.12174/j.issn.2096-9600.2022.04.13]
[11]诸凡凡,叶 柏△.腹泻型肠易激综合征发病机制及治疗现状[J].西部中医药,2013,26(10):139.
　ZHU Fanfan,YE Bai.Current State of the Treatment and Pathogenesis of Diarrhea Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2013,26(03):139.
[12]周荣,彭琪,张敏.人参败毒散加味治疗腹泻型肠易激综合征 54 例[J].西部中医药,2014,27(08):52.
[13]牛立军,苏强,刘振伟,等.安肠止痛组方联合曲美布汀治疗腹泻型肠易激综合征 78 例[J].西部中医药,2014,27(08):81.
[14]张丽娜,刘则鹏,廖志峰.泻肝健脾补肾汤治疗腹泻型肠易激综合征疗效观察[J].西部中医药,2014,27(09):120.
[15]寇媛,赵倩,闻新丽,等.中医三联疗法治疗腹泻型肠易激综合征疗效观察[J].西部中医药,2015,28(11):79.
[16]曹俊,赵智强△.赵智强教授辨治腹泻型肠易激综合征经验介绍[J].西部中医药,2018,31(04):56.
　CAO Jun,ZHAO Zhiqiang.Professor Zhao Zhiqiang′s Experience of Differentiating and Treating Diarrhea-type Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2018,31(03):56.
[17]雷超芳,翟昌明,马重阳,等.王庆国教授辨治腹泻型肠易激综合征经验[J].西部中医药,2020,33(03):62.[doi:10.12174/j.issn.1004-6852.2020.03.17]
　LEI Chaofang,ZHAI Changming,MA Chongyang,et al.Professor Wang Qingguo's Experience in Differentiating and Treating Diarrhea - predominant Pattern Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2020,33(03):62.[doi:10.12174/j.issn.1004-6852.2020.03.17]
[18]张伟健,黄彦子,陈新博,等.郭绍举主任运用水湿内停方治疗肠易激综合征的经验[J].西部中医药,2022,35(03):57.[doi:10.12174/j.issn.2096-9600.2022.03.13]
　ZHANG Weijian,HUANG Yanzi,CHEN Xinbo,et al.Director Guo Shaoju’s Experience in Treating Diarrhea-predominant Irritable Bowel Disease by Water-damp Internal Retention Prescription[J].Western Journal of Traditional Chinese Medicine,2022,35(03):57.[doi:10.12174/j.issn.2096-9600.2022.03.13]
[19]谢小玲,黄适,何锦轶,等.基于中医病因学说探讨HMGB1与IBS-D的相关性[J].西部中医药,2023,36(05):112.[doi:10.12174/j.issn.2096-9600.2023.05.26]
　XIE Xiaoling,HUANG Shi,HE Jinyi,et al.The Correlation between HMGB1 and IBS-D from the Etiology of TCM[J].Western Journal of Traditional Chinese Medicine,2023,36(03):112.[doi:10.12174/j.issn.2096-9600.2023.05.26]

备注/Memo

备注/Memo:
张霞（1974—），女，副主任医师。研究方向：消化系统疾病的中医药防治。
更新日期/Last Update: 2023-03-15